Arkolith/Insider Trading/RAPP/Form 4

Gault Cheryl

Chief Operating OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$416K
Net Open-Market Flow
-$416K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Sell(S)2K$40.09$76K158K
Jun 30, 2026Sell(S)4K$41.39$157K154K
Jun 30, 2026Sell(S)3K$42.17$140K151K
Jun 30, 2026Sell(S)1K$43.15$43K150K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-292546) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML